S Delorme1, F De Guio1,2, S Reyes3, A Jabouley3, H Chabriat1,2,3, E Jouvent4,2,3. 1. From the University Paris Diderot (S.D., F.D.G., H.C., E.J.), Sorbonne Paris Cité, UMR-S 1161 INSERM, Paris, France. 2. DHU NeuroVasc Sorbonne Paris Cité (F.D.G., H.C., E.J.), Paris, France. 3. Department of Neurology (S.R., A.J., H.C., E.J.), AP-HP, Lariboisière Hospital, Paris, France. 4. From the University Paris Diderot (S.D., F.D.G., H.C., E.J.), Sorbonne Paris Cité, UMR-S 1161 INSERM, Paris, France eric.jouvent@aphp.fr.
Abstract
BACKGROUND AND PURPOSE: Reaction time was recently recognized as a marker of subtle cognitive and behavioral alterations in the early clinical stages of CADASIL, a monogenic cerebral small-vessel disease. In unselected patients with CADASIL, brain atrophy and lacunes are the main imaging correlates of disease severity, but MR imaging correlates of reaction time in mildly affected patients are unknown. We hypothesized that reaction time is independently associated with the corpus callosum area in the early clinical stages of CADASIL. MATERIALS AND METHODS: Twenty-six patients with CADASIL without dementia (Mini-Mental State Examination score > 24 and no cognitive symptoms) and without disability (modified Rankin Scale score ≤ 1) were compared with 29 age- and sex-matched controls. Corpus callosum area was determined on 3D-T1 MR imaging sequences with validated methodology. Between-group comparisons were performed with t tests or χ2 tests when appropriate. Relationships between reaction time and corpus callosum area were tested using linear regression modeling. RESULTS: Reaction time was significantly related to corpus callosum area in patients (estimate = -7.4 × 103, standard error = 3.3 × 103, P = .03) even after adjustment for age, sex, level of education, and scores of depression and apathy (estimate = -12.2 × 103, standard error = 3.8 × 103, P = .005). No significant relationship was observed in controls. CONCLUSIONS: Corpus callosum area, a simple and robust imaging parameter, appears to be an independent correlate of reaction time at the early clinical stages of CADASIL. Further studies will determine whether corpus callosum area can be used as an outcome in future clinical trials in CADASIL or in more prevalent small-vessel diseases.
BACKGROUND AND PURPOSE: Reaction time was recently recognized as a marker of subtle cognitive and behavioral alterations in the early clinical stages of CADASIL, a monogenic cerebral small-vessel disease. In unselected patients with CADASIL, brain atrophy and lacunes are the main imaging correlates of disease severity, but MR imaging correlates of reaction time in mildly affected patients are unknown. We hypothesized that reaction time is independently associated with the corpus callosum area in the early clinical stages of CADASIL. MATERIALS AND METHODS: Twenty-six patients with CADASIL without dementia (Mini-Mental State Examination score > 24 and no cognitive symptoms) and without disability (modified Rankin Scale score ≤ 1) were compared with 29 age- and sex-matched controls. Corpus callosum area was determined on 3D-T1 MR imaging sequences with validated methodology. Between-group comparisons were performed with t tests or χ2 tests when appropriate. Relationships between reaction time and corpus callosum area were tested using linear regression modeling. RESULTS: Reaction time was significantly related to corpus callosum area in patients (estimate = -7.4 × 103, standard error = 3.3 × 103, P = .03) even after adjustment for age, sex, level of education, and scores of depression and apathy (estimate = -12.2 × 103, standard error = 3.8 × 103, P = .005). No significant relationship was observed in controls. CONCLUSIONS: Corpus callosum area, a simple and robust imaging parameter, appears to be an independent correlate of reaction time at the early clinical stages of CADASIL. Further studies will determine whether corpus callosum area can be used as an outcome in future clinical trials in CADASIL or in more prevalent small-vessel diseases.
Authors: Susumu Mori; Kenichi Oishi; Hangyi Jiang; Li Jiang; Xin Li; Kazi Akhter; Kegang Hua; Andreia V Faria; Asif Mahmood; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa Neto; Alan Evans; Jiangyang Zhang; Hao Huang; Michael I Miller; Peter van Zijl; John Mazziotta Journal: Neuroimage Date: 2008-01-03 Impact factor: 6.556
Authors: Hanna Jokinen; Charlotte Ryberg; Hely Kalska; Raija Ylikoski; Egill Rostrup; Mikkel B Stegmann; Gunhild Waldemar; Sofia Madureira; José M Ferro; Elizabeth C W van Straaten; Philip Scheltens; Frederik Barkhof; Franz Fazekas; Reinhold Schmidt; Giovanna Carlucci; Leonardo Pantoni; Domenico Inzitari; Timo Erkinjuntti Journal: J Neurol Neurosurg Psychiatry Date: 2006-10-06 Impact factor: 10.154
Authors: G Bergendal; J Martola; L Stawiarz; M Kristoffersen-Wiberg; S Fredrikson; O Almkvist Journal: Acta Neurol Scand Date: 2012-09-18 Impact factor: 3.209
Authors: François De Guio; Marco Duering; Franz Fazekas; Frank-Erik De Leeuw; Steven M Greenberg; Leonardo Pantoni; Agnès Aghetti; Eric E Smith; Joanna Wardlaw; Eric Jouvent Journal: J Cereb Blood Flow Metab Date: 2019-11-20 Impact factor: 6.200
Authors: Tor-Björn Claesson; Jukka Putaala; Sara Shams; Eero Salli; Daniel Gordin; Ron Liebkind; Carol Forsblom; Paula A Summanen; Turgut Tatlisumak; Per-Henrik Groop; Juha Martola; Lena M Thorn Journal: Front Neurol Date: 2020-01-29 Impact factor: 4.003